Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of June 2025, with a specific reporting date of June 3, 2025. The document serves as a notification and public disclosure under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). Haleon is a global leader in consumer health with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a specific equity transaction involving a company executive.
Material Changes and Transaction Details
The filing details a share transaction involving Ed Petter, Chief Corporate Affairs Officer, on June 2, 2025:
- Acquisition: Mr. Petter acquired 51,584 Ordinary Shares at a price of Nil. This represented the first tranche vesting of a Haleon Share Value Plan award granted as part of his remuneration to compensate for forfeited incentives from previous employment.
- Disposal: To cover tax liabilities associated with the vesting, 24,305.243108 Ordinary Shares were automatically disposed of on the London Stock Exchange (XLON) at a price of £4.134623 per share.
- Terms: The award is subject to malus and clawback provisions.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard regulatory disclosure of the PDMR transaction. No unusual items affecting financial results are reported in this document.
Investor Verification Checklist
- Verify the total number of shares held by Ed Petter following the net acquisition (51,584 acquired minus 24,305.24 disposed).
- Confirm the specific vesting schedule and performance conditions for the remaining unvested portion of the Share Value Plan award.
- Review the Company's latest Form 20-F or quarterly earnings release for actual financial performance metrics, as this 6-K does not provide them.